600 filings
Page 13 of 30
8-K
cqg7s wgd3e6t
26 Feb 18
Other Events
12:00am
8-K
rcw5daa7abj32dl
15 Feb 18
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
12:00am
424B5
l9cvi benldpr
14 Feb 18
Prospectus supplement for primary offering
12:00am
424B5
40ctb9o7ttyu
12 Feb 18
Prospectus supplement for primary offering
12:00am
8-K
wp4w385s7qe9gcrmy
12 Feb 18
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
12:00am
8-K
npsw 5d4u9otdgzke4e
12 Feb 18
Other Events
12:00am
8-K
trn3nz9oop2 u1h
9 Feb 18
Catalyst Biosciences Announces PositiveTop-Line Data from Phase 1/2 Study of
12:00am
EFFECT
i22gmnb8
6 Feb 18
Notice of effectiveness
12:00am
CORRESP
vam ylw1z8
2 Feb 18
Correspondence with SEC
12:00am
UPLOAD
qj62uru
30 Jan 18
Letter from SEC
12:00am
8-K
vxrai 2fxn0
17 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
wu129f
4 Jan 18
Other Events
12:00am
8-K
mcuda iqm5zlr1jxtnui
22 Dec 17
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
12:00am
424B5
bast43m5 mg5
21 Dec 17
Prospectus supplement for primary offering
12:00am
8-K
3q0 etaxfo456
20 Dec 17
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
12:00am
424B5
fmc9782zm910ttlf
19 Dec 17
Prospectus supplement for primary offering
12:00am
8-K
ks7husj
18 Dec 17
Catalyst Biosciences Announces Acceleration of Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B
12:00am
8-K
sxy43w
14 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
5oyvdvx9id1tl nu
11 Dec 17
Regulation FD Disclosure
12:00am